1.       Adler SP. Transfusion associated cytomegalovirus infections. Rev Infect Dis. 1983; 5: 977-983.

2.       Banatvala JE, Brown DW. Rubella. Lancet. 2004; 363: 1127-1137.

3.      Berger F, Goulet V, Le Strat Y,et al. Toxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003. Rev Epidemiol Sante Publique. 2009;57:241.

4.       Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis. 2013;57:178–181.

5.       Chakraborty R, Luck S. Managing congenital syphilis again? The more things change. Curr Opin Infect Dis. 2002; 20: 247-252.

6.      Curdt I, Praast G, Sickinger E, et al. Development of fully automated determination of marker-specific immünoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays. Journal of clinical microbiology. 2009;47:603-613.

7.       Cutts FT, Robertson SE, Diaz- Ortega JL, et al. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part I: Burden of disaese from CRS. Bull World health organ. 1997; 75: 55-68.

8.      Dubey J, Lindsay D, Speer C. Structures of T.gondii tachyzoites,  bradyzoites, and sporozoites and biology and development of tissue cysts. Clinical Microbiology Reviews. 1998;11:267-299.

9.      Dubey JP. Toxoplasmosis of animals and humans. 2nd ed. Boca Raton: CRC Press; 2010.

10.  Fanaroff AA, Martin RJ, Walsh MC. Fanaroff and Martin’s Neonatal-Perinatal Medicine. 12th ed. Elsevier; 2021.

11.   Fowler KB, Stagno S, Pass RF, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992;663-667.

12.  Gomella TL, Eyal FG, Bany-Mohammed F. Neonatology: Management, Procedures, On-Call Problems, Diseases, and Drugs. 8th ed. McGraw-Hill Education; 2020.

13.   Grillner L, Forsgren M, Barr B,et al. Outcome of rubella during pregnancy with special reference to the 17th-24th weeks of gestation. Scand J Infect Dis. 1983;15: 321-325.

14.   Hohlfeld P, Vial Y, Maillard –Brignon C, et al. Cytomegalovirus fetal infection: prenatal diagnosis. Obstet Gynecol.1991;78:615.

15.   Kimberlin DW, Acosta EP, Sanchez PJ, et al. Pharmacokinetic and pharmacodynamics assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197:836–845.

16.   Kimberlin DW, Lin CY, Jacobs RF, et al. National Institude of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Natural history of neonatal herpes simplex virüs infections in the acylovir era. Pediatrics. 2001; 108: 223-229.

17.  Kota AS, Shabbir N. Congenital Toxoplasmosis. 2023 Jun 26. In: StatPearls[Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 31424812. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545228/.

18.  Liu Q, Wang ZD, Huang SY, et al. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit vectors. 2015;8:292.

19.   Miller E. Rubella in the United Kingdom. Epidemiol Infect.1991; 107: 31-42.

20.  Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965-1976.

21.  Montoya JG. Laboratory diagnosis of T.gondii infection and toksoplasmosis. The Journal of Infectious Diseases. 2002;185:73-82.

22.  Özdemir B. Toxoplasma enfeksiyonunun tanısında toxoplasma IgG avidite testinin yeri.\The role of toxoplasma igg avidity test in the diagnosis of toxopalsma infection. Gaziantep: Gaziantep Üniversitesi Sağlık Bilimleri Enstitüsü. 2006.

23.  Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39:1385-1394.

24.  Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25:264-296.

25.   Scott LL, Hollier LM, McIntire D, et al. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial. Infect Dis Obstet Gynecol. 2001; 9:75-80.

26.  Sepúlveda-Arias JC, Gómez-Marin JE, Bobić B, et al. Toxoplasmosis as a travel risk. Travel medicine and infectious disease. 2014;12:592-560.

27.   Shet A. Congenital and perinatal infections: throwing new light with an old TORCH. Indian J Pediatr. 2011; 78:88-95.

28.  Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30:1217-1258.

29.   Walker DG, Walker GJ. Prevention of congenital syphilis- time for action. Bull World Health Organ. 2004; 82: 401.